Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Passover under fire: Israelis balance fatigue with cautious hope after month of war - 2Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- 3Eleven Creations And Developments That Steered History
- 4Step by step instructions to Guarantee Your Lab Precious stone is Morally Obtained
- 5A top Marine shares his secrets to keeping fit at 50
- Scientists solve the mystery of the prehistoric 'Burtele Foot'
- Solar storms can trigger auroras on Earth. This star’s explosion could destroy a planet’s atmosphere
- NASA launches science balloon in Antarctica | Space photo of the day for Dec. 22, 2025
- The World's Dazzling Regular Miracles
- From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- First foreign troop in new gang suppression force lands in Haiti to replace previous mission
- People are getting their news from AI – and it’s altering their views
- Monetary Security: Building Serious areas of strength for an Establishment
- 1st-ever disease gene fix, Alzheimer's blood test: 7 medical breakthroughs in 2025
